{"id":1342,"date":"2026-04-28T17:42:47","date_gmt":"2026-04-28T17:42:47","guid":{"rendered":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/startup\/targeted-c-difficile-therapeutics\/"},"modified":"2026-05-02T00:30:05","modified_gmt":"2026-05-02T00:30:05","slug":"targeted-c-difficile-therapeutics","status":"publish","type":"startup","link":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/startup\/targeted-c-difficile-therapeutics\/","title":{"rendered":"Targeted C. difficile Therapeutics"},"content":{"rendered":"","protected":false},"featured_media":954,"parent":0,"template":"","startup-category":[],"industry":[6],"opportunity":[23,27],"class_list":["post-1342","startup","type-startup","status-publish","has-post-thumbnail","hentry","industry-pharma","opportunity-ceo-business-lead","opportunity-founder"],"acf":[],"_links":{"self":[{"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/startup\/1342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/startup"}],"about":[{"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/types\/startup"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/media\/954"}],"wp:attachment":[{"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/media?parent=1342"}],"wp:term":[{"taxonomy":"startup-category","embeddable":true,"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/startup-category?post=1342"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/industry?post=1342"},{"taxonomy":"opportunity","embeddable":true,"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/opportunity?post=1342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}